About PAG
PAG is a company based in China. It operates as a B2B. PAG has completed 31 acquisitions, including Acme Generics, Anjan Drug and BioRay Pharmaceutical.
- Headquarter China
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pagac Advisors India Private Limited
- Date of Incorporation 11 Apr, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$3.46 M (USD)-3.52as on Mar 31, 2023
-
Net Profit
$438.28 K (USD)-1.58as on Mar 31, 2023
-
EBITDA
$2.23 M (USD)37.11as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Acme Generics
& 30 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of PAG
Unlock access to complete
Unlock access to complete
Funding Insights of PAG
Detailed funding history for PAG
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PAG
PAG has strategically engaged in corporate development activities, having acquired 31 companies. Notable acquisitions include Acme Generics, Anjan Drug and BioRay Pharmaceutical.
Investment portfolio details for PAG
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Antibody therapeutics for immunology and oncology are developed.
|
Locked | Locked | 2019 | Locked | |
|
Nutrition consulting services are provided to clients worldwide.
|
Locked | Locked | 2019 | Locked | |
|
Residential building development services are provided in Hong Kong.
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for PAG
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PAG
Detailed financials for PAG
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pag Comparisons
Peer comparison for PAG
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PAG
Detailed competitors of PAG
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pag
Complete news archive for PAG
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PAG
PAG is headquartered in China.
Annual revenue of PAG is $3.46M as on Mar 31, 2023.
Capital is managed for institutional investors through strategies in private equity, real assets, credit, and markets within the alternative investment sector. Operations center on generating returns alongside integration of environmental, social, and governance factors. ESG issues are analyzed thoroughly in the investment process to support sustainable value over the long term. Services target institutional fund investors with a focus on responsible practices.
PAG has made 31 acquisitions, including Acme Generics, Anjan Drug, and BioRay Pharmaceutical.